Morning Brew Daily cover image

Morning Brew Daily

Psychedelics Treating PTSD? & Why So Many Musicians are Canceling Concerts

Jun 3, 2024
29:32
Snipd AI
Exploring the potential FDA approval of MDMA for treating PTSD. Elon Musk seeks approval for a $47 billion pay package. Concert industry struggles as artists cancel tours. Mexico elects first female Jewish president. Lego gains popularity with adults. Economic updates and sports highlights included.
Read more

Podcast summary created with Snipd AI

Quick takeaways

  • FDA scrutiny on MDMA for PTSD treatment, raising doubts on its effectiveness.
  • Pushback against Elon Musk's $46 billion pay package, facing investor criticism.

Deep dives

Controversy over MDMA Drug for PTSD Treatment

An MDMA drug for treating PTSD is facing scrutiny due to a study indicating potential issues. Lycos Therapeutics tested the drug on adults with PTSD, claiming positive outcomes, but the study methodology raised concerns. The FDA's assessment of the study's evidence exposes doubts regarding the drug's effectiveness, challenging a longstanding effort to promote psychedelic drugs for medical use.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode